Telomerase inhibition by peptide nucleic acids reverses `immortality' of transformed human cells
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Telomerase activity, the ability to add telomeric repeats to the ends of chromosomes, has been detected in most immortal cell lines including tumor cells, but is low or absent in most diploid, mortal cells such as those of somatic tissues. Peptide nucleic acids (PNAs), analogs of DNA or RNA which bind to complementary nucleic acids with very high affinity, were co-electroporated into immortal human cells along with a selectable plasmid. Introduction of PNAs inverse-complementary to telomerase RNA effectively inhibited telomerase activity in intact cells, shortened telomeres, reduced colony size, and arrested cell proliferation after a lag period of 5-30 cell generations, consistent with suppression of their 'immortality'. Electroporation of selection plasmid alone had no effect, while PNAs of altered sequence were markedly less effective in each assay. This constitutes the first demonstration of cell growth arrest through telomerase inhibition, upon treatment of intact cells with an exogenous compound which can be efficiently delivered in vivo. The phenotype of telomerase-inhibited transformed cells differs from senescence of normal diploid fibroblasts, but rather resembles the crisis state of incompletely transformed cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent work with PNAs introduced into cells by electroporation has shown decreased cell viability, supporting our findings (49).”
From Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death (1999) · cites this paper as [49]
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 2×
“…repeats (TTAGGG in mammals) to the ends of chromosomes, is undetectable in most diploid, `mortal' cell types and strains (Counter et al., 1992; Kim et al., 1994), but has been observed in a majority of `immortal' cell lines ± aneuploid cells, whether tumor-derived or transformed in vitro,…”
BackgroundTelomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Sequence-Selective Recognition of DNA by Strand Displacement with a Thymine-Substituted Polyamide
Nielsen, P. E., Egholm, M., Berg, R. H., & Buchardt, O. (1991) · Science · doi:10.1126/science.1962210 · Cited by 3,332 · cited 1×
“These molecules are resistant to biodegradation (Demidov et al., 1994) and anneal by Watson:Crick base-pairing to complementary RNA or DNA sequences with much higher a nity than the corresponding phosphodiester oligomers (Nielsen et al., 1991; Egholm et al., 1993).”
BackgroundA survey of telomerase activity in human cancer
Shay, J. W., & Bacchetti, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00062-2 · Cited by 2,794 · cited 1×
“…activity is observed in most neoplastic cells and tissues yet is low or absent in somatic tissues (Kim et al., 1994; Broccoli et al., 1995; Shay and Bacchetti, 1997), inhibitors of telomerase activity hold promise as anti-cancer agents which might attenuate the growth of tumors while…”
BackgroundThe RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227 · cited 2×
“…appeared to enter crisis (see below), much as reported for HeLa cell clones stably transfected with a plasmid expressing antisense telomerase RNA (Feng et al., 1995), and for a human glioblastoma line stably transfected with the same anti-telomerase plasmid, although a subset of di erentiated…”
BackgroundTelomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096 · cited 1×
“…ability to add telomeric repeats (TTAGGG in mammals) to the ends of chromosomes, is undetectable in most diploid, `mortal' cell types and strains (Counter et al., 1992; Kim et al., 1994), but has been observed in a majority of `immortal' cell lines ± aneuploid cells, whether tumor-derived or…”
Background
Research works printed but not linked: 1
- Reid LH, Shesely EG, Kim HS and Smithies O. . 1991 Mol. Cell. Biol. 11: 2769–2777. · doi:10.1128/mcb.11.5.2769-2777.1991 · Paper page
Cited by
Items 101–156 of 156
Telomerase: diagnostics, cancer therapeutics and tissue engineering
Ouellette, M. M., & Lee, K. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)02052-9 · Cited by 14
Telomerase inhibitors: a new option for chemotherapy
Chen, Z., & Corey, D. R. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)87173-7 · Cited by 15
Self-citationTelomeres, cancer & aging: live long & prosper?
Eissenberg, J. C. (2013) · Europe PMC (PubMed Central) · Cited by 12
Replicative Senescence and Cancer
Hornsby, P. J. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-387-23962-6_3 · Cited by 11
Telomerase inhibitors: a new option for chemotherapy
Chen, Z. J., & Corey, D. R. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)87294-9 · Cited by 11
Self-citationDesign of a ribozyme targeting human telomerase reverse transcriptase and cloning of it’s gene
Hao, Z., Luo, J., 程晋, Quan-yin, W., & Yang, G.-X. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i1.104 · Cited by 11
Cancer Cell Dynamics in Presence of Telomerase Inhibitors: Analysis of In Vitro Data
Sidorov, I. A., Hirsch, K. S., Harley, C. B., & Dimitrov, D. S. (2002) · Journal of Theoretical Biology · doi:10.1006/jtbi.2002.3117 · Cited by 9
Recombination and its roles in DNA repair, cellular immortalization and cancer
Shammas, M. A., & Reis, R. J. S. (1999) · AGE · doi:10.1007/s11357-999-0009-0 · Cited by 9
Self-citationChaperones and Their Role in Telomerase Ribonucleoprotein Biogenesis and Telomere Maintenance
Viviescas, M. A., Cano, M. I. N., & Segatto, M. (2018) · Current Proteomics · doi:10.2174/1570164615666180713103133 · Cited by 8
Nielsen, P. E. (2007) · Springer eBooks · doi:10.1007/0-387-32956-0_1 · Cited by 8
Computationally Designed Peptide Inhibitors of the Ubiquitin E3 Ligase SCFFbx4
Lee, J., Sammond, D. W., Fiorini, Z., Saludes, J. P., Resch, M. G., Hao, B., Wang, W., Yin, H. H., & Liu, X. (2013) · ChemBioChem · doi:10.1002/cbic.201200777 · Cited by 8
Ballon, G., Trentin, L., Rossi, A. D., & Semenzato, G. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109057952 · Cited by 8
Enhanced antisense effect of modified PNAs delivered through functional PMMA microspheres
Chiarantini, L., Cerasi, A., Millo, E., Sparnacci, K., Laus, M., Riccio, M., Santi, S., Ballestri, M., Spaccasassi, S., & Tondelli, L. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.07.007 · Cited by 7
Peptide nucleic acids: Cellular delivery and recognition of DNA and RNA targets
Corey, D. R. (2003) · International Journal of Peptide Research and Therapeutics · doi:10.1007/bf02484569 · Cited by 7
Self-citationPeptide–Peptide Nucleic Acid Conjugates for Modulation of Gene Expression
Fabani, M. M., Ivanova, G. D., & Gait, M. J. (2008) · Royal Society of Chemistry eBooks · doi:10.1039/9781847558275-00080 · Cited by 6
Jiang, Y., Luo, H.-S., Fan, L., Jiang, C.-Q., & Chen, W.-J. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i3.443 · Cited by 6
Clinical applications of telomerase in cancer treatment
Faraoni, I., Bonmassar, E., & Graziani, G. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0139 · Cited by 6
Tan, X., Bruchez, M. P., & Armitage, B. A. (2018) · ChemBioChem · doi:10.1002/cbic.201800709 · Cited by 5
Artificial genetic polymers against human pathologies
Ivanov, G. S., Tribulovich, V. G., Pestov, N. B., David, T. I., Amoah, A.-S., Korneenko, T. V., & Barlev, N. A. (2022) · Biology Direct · doi:10.1186/s13062-022-00353-7 · Cited by 5
Development of telomerase inhibitors
Rowley, P. T. (2001) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.11.12.1815 · Cited by 5
Robinson, M. O. (2000) · Springer eBooks · doi:10.1007/978-1-4615-4199-8_12 · Cited by 5
Telomerase in human tumors: molecular diagnosis andclinical significance
Dahse, R., & Mey, J. (2001) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.1.2.201 · Cited by 5
Blockade of Plasmid Replication Mediated by Peptide Nucleic Acids
Liebling, M. R., Jou, N. T., Fang, W., & Louie, J. S. (2003) · Molecular Biotechnology · doi:10.1385/mb:25:3:229 · Cited by 4
Nielsen, P. E. (2003) · International Journal of Peptide Research and Therapeutics · doi:10.1007/bf02484555 · Cited by 4
Interfaces hybrides organiques-inorganiques pour applications biomédicales
Bertucci, A. (2015) · theses.fr (ABES) · doi:10.70675/45cc3273z233bz452ezb7a2zd77fc75a19b6 · Cited by 3
Computationally Designed Peptide Inhibitors against the Ubiquitin E3 Ligase SCF Fbx4
Hao, B. (2013) · OpenCommons - UConn (University of Connecticut) · Cited by 2
Nonviral Approaches for Cancer Gene Therapy
Huang, L., & Lui, V. W. Y. (2003) · CRC Press eBooks · doi:10.1201/9780203912331-14 · Cited by 2
Telomerase - strategies to exploit an important chemotherapeutic target
Fletcher, T. M. (2001) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.5.3.363 · Cited by 2
Luminescent phenanthridinyl-containing rhenium tricarbonyl complexes
Raszeja, L. J. (2012) · Dokumentenrepositorium der RUB (Ruhr University Bochum) · Cited by 2
Nielsen, P. E. (2005) · Letters in Peptide Science · doi:10.1007/s10989-005-4860-2 · Cited by 2
Peptide nucleic acids as epigenetic inhibitors of HIV-1
Sei, S. (2003) · International Journal of Peptide Research and Therapeutics · doi:10.1007/bf02484563 · Cited by 2
DNA Delivery to Cells in Culture Using PNA Clamps
Giorgio, T. D., & Wyatt, S. K. (2004) · Humana Press eBooks · doi:10.1385/1-59259-649-5:53 · Cited by 1
DNA instability, telomere dynamics, and cell transformation
Reis, R. J. S., & Shammas, M. A. (2001) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(01)04031-7 · Cited by 1
Self-citationCysteine based PNA (CPNA): Design, synthesis and application
Yi, S. W. (2008) · Digital Commons - University of South Florida (University of South Florida) · Cited by 1
Telomerasa: regulación, diana terapéutica y significado clínico en neoplasias humanas
Albanell, J. (2001) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya) · Cited by 1
Peptide Nucleic Acids as Epigenetic Inhibitors of HIV-1
Sei, S. (2007) · Springer eBooks · doi:10.1007/0-387-32956-0_9 · Cited by 1
Peptide nucleic acids: Cellular delivery and recognition of DNA and RNA targets
Corey, D. R. (2005) · Letters in Peptide Science · doi:10.1007/s10989-005-4902-9 · Cited by 1
Self-citationTelomeres, Telomerase, Chromosome Stability, and Prostate Cancer
Meeker, A. K. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-224-3_18 · Cited by 1
Synthesis and properties of amino- and guanidino-peptoid peptide nucleic acids
Lu, X. W. (2010) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/40210
Corey, D. R. (2007) · Springer eBooks · doi:10.1007/0-387-32956-0_15
Self-citationAnti-Aging Medicine LiteratureWatch
Pawelec, G. (1998) · Rejuvenation Research · doi:10.1089/rej.1.1998.1.275
Nachweis der Telomeraseaktivität bei Patienten mit Tumoren im Kopf-Hals-Bereich
Sonntag, J. M. (2007) · Common Library Network (Der Gemeinsame Bibliotheksverbund)
Mechanistic Studies of the E3 Ubiquitin Ligases SCF(Fbx4) and Parkin
Lee, J. (2014) · CU Scholar (University of Colorado Boulder)
Proliferación celular y regulación de la telomerasa en el cancer de mama
Diaz, G. S., & Jose, J. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Peptide nucleic acids as epigenetic inhibitors of HIV-1
Sei, S. (2003) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-004-4925-7
Anti-Aging Medicine LiteratureWatch
Pawelec, G. (2000) · Rejuvenation Research · doi:10.1089/rej.1.2000.3.113
Peptide nucleic acids as epigenetic inhibitors of HIV-1
Sei, S. (2005) · Letters in Peptide Science · doi:10.1007/s10989-005-4925-2
Characterization of distinct and conserved features between ciliate and vertebrate telomerases
Marie-Egyptienne, D. T. (2008) · doi:10.82308/35713
Martín, R. R. (2007) · Repository of Digital Objects for Teaching Research and Culture (University of Valencia)
Identification of telomere binding region and ribozyme target site in human telomerase RNA
�뿬留먰씗 (2003) · YUHSpace (Yonsei University Medical Library)
Vers la synthèse d’acides nucléiques N-oxy peptidiques et synthèse de ribosondes
Noël, O. (2013) · theses.fr (ABES) · doi:10.70675/e5a02cfdzbd9fz4a55z9033zdaa55d41bf06
Cellular analysis and PNA encoded libraries
Svensen, N. (2011) · ERA
Tuning PNA Properties by Chemical Modifications: Design Synthesis and Applications
Calabretta, A. (2010) · DSpaceUnipr (University of Parma)
Jackson, M. R. (2013) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-kqqbrkdad
Metadata
- Authors
- Shammas, M. A., Simmons, C. G., Corey, D. R., & Shmookler Reis, R. J.
- Affiliations
- University of Arkansas for Medical Sciences (US)
- Howard Hughes Medical Institute (US)
- Venue
- Oncogene
- Published
- 1999-11-04
- Volume
- 18
- Issue
- 46
- Pages
- 6191-6200
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2093249575
- Cited by
- 135
- References
- 52
- Citations by year
- 2022: 2 · 2021: 2 · 2020: 1 · 2019: 2 · 2018: 2 · 2017: 3 · 2015: 2 · 2014: 1 · 2013: 4 · 2012: 1
- FWCI
- 8.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- telomerase inhibition, peptide nucleic acid, telomere shortening, cell immortalization, growth arrest, electroporation, telomerase RNA, senescence, cancer cells
- MeSH terms
- Amino Acid Metabolism, Inborn Errors, Ataxia Telangiectasia, Cell Division, Cell Line, Transformed, Cell Transformation, Neoplastic, Enzyme Induction, Enzyme Inhibitors, Humans, RNA, Messenger, Transfection, Cellular Senescence, Electroporation, Telomerase, Peptide Nucleic Acids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.